Shares

41 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$309.38 - $337.38 $972,381 - $1.06 Million
-3,143 Reduced 15.52%
17,114 $5.51 Billion
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $5.32 Million - $6.47 Million
20,257 New
20,257 $6.33 Billion
Q1 2024

Jul 09, 2025

BUY
$268.87 - $324.56 $8.22 Million - $9.92 Million
30,575 New
30,575 $8.69 Billion
Q4 2023

Jul 09, 2025

SELL
$255.7 - $288.46 $39,122 - $44,134
-153 Reduced 0.44%
34,478 $9.93 Billion
Q3 2023

Jul 09, 2025

BUY
$218.65 - $271.46 $1.96 Million - $2.43 Million
8,949 Added 34.85%
34,631 $9.31 Billion
Q2 2023

Jul 09, 2025

SELL
$214.27 - $253.37 $430,039 - $508,513
-2,007 Reduced 7.25%
25,682 $5.7 Billion
Q4 2022

Jul 09, 2025

BUY
$229.03 - $291.01 $976,812 - $1.24 Million
4,265 Added 18.21%
27,689 $7.27 Billion
Q3 2022

Jul 09, 2025

SELL
$224.46 - $253.15 $67,113 - $75,691
-299 Reduced 1.26%
23,424 $5.28 Billion
Q2 2022

Jul 09, 2025

BUY
$230.71 - $256.74 $90,899 - $101,155
394 Added 1.69%
23,723 $5.77 Billion
Q1 2022

Jul 09, 2025

BUY
$219.27 - $242.57 $5.12 Million - $5.66 Million
23,329 New
23,329 $5.64 Billion
Q4 2021

Jul 09, 2025

BUY
$198.88 - $227.6 $941,299 - $1.08 Million
4,733 Added 25.05%
23,625 $5.31 Billion
Q3 2021

Jul 09, 2025

SELL
$212.27 - $248.7 $34,812 - $40,786
-164 Reduced 0.86%
18,892 $4.02 Billion
Q2 2021

Jul 09, 2025

SELL
$233.58 - $259.14 $2.46 Million - $2.73 Million
-10,519 Reduced 35.57%
19,056 $4.64 Billion
Q1 2021

Jul 09, 2025

BUY
$221.91 - $258.6 $6.56 Million - $7.65 Million
29,575 New
29,575 $7.36 Billion
Q4 2020

Jul 08, 2025

SELL
$216.38 - $257.67 $222,655 - $265,142
-1,029 Reduced 1.94%
52,105 $12 Billion
Q3 2020

Jul 08, 2025

SELL
$234.65 - $260.95 $433,163 - $481,713
-1,846 Reduced 3.36%
53,134 $13.5 Billion
Q2 2020

Jul 08, 2025

BUY
$197.81 - $242.74 $1.15 Million - $1.42 Million
5,833 Added 11.87%
54,980 $13 Billion
Q1 2020

Jul 08, 2025

BUY
$182.24 - $241.7 $160,006 - $212,212
878 Added 1.82%
49,147 $9.96 Billion
Q4 2019

Jul 08, 2025

SELL
$189.21 - $243.2 $2.31 Million - $2.97 Million
-12,216 Reduced 20.2%
48,269 $11.6 Billion
Q3 2019

Jul 08, 2025

SELL
$174.11 - $208.62 $95,934 - $114,949
-551 Reduced 0.9%
60,485 $11.7 Billion
Q2 2019

Jul 08, 2025

BUY
$166.7 - $195.41 $162,199 - $190,133
973 Added 1.62%
61,036 $11.2 Billion
Q1 2019

Jul 08, 2025

SELL
$180.87 - $203.88 $35,088 - $39,552
-194 Reduced 0.32%
60,063 $11.4 Billion
Q4 2018

Jul 08, 2025

BUY
$178.4 - $208.25 $10.7 Million - $12.5 Million
60,257 New
60,257 $11.7 Billion
Q3 2018

Jul 08, 2025

BUY
$185.29 - $208.89 $309,434 - $348,846
1,670 Added 3.65%
47,409 $9.83 Billion
Q2 2018

Jul 08, 2025

SELL
$166.05 - $186.51 $294,406 - $330,682
-1,773 Reduced 3.73%
45,739 $8.44 Billion
Q1 2018

Jul 08, 2025

BUY
$169.43 - $198.0 $46,593 - $54,450
275 Added 0.58%
47,512 $8.1 Billion
Q4 2017

Jul 08, 2025

SELL
$168.79 - $188.59 $180,605 - $201,791
-1,070 Reduced 2.21%
47,237 $8.21 Billion
Q3 2017

Jul 08, 2025

BUY
$167.29 - $191.0 $396,310 - $452,479
2,369 Added 5.16%
48,307 $9.01 Billion
Q2 2017

Jul 08, 2025

SELL
N/A
-33,770 Reduced 42.37%
45,938 $7.91 Billion
Q1 2017

Jul 08, 2025

BUY
N/A
1,850 Added 2.38%
79,708 $13.1 Billion
Q4 2016

Jul 08, 2025

SELL
N/A
-8,378 Reduced 9.72%
77,858 $11.4 Billion
Q3 2016

Jul 08, 2025

BUY
N/A
65,323 Added 312.36%
86,236 $14.4 Billion
Q2 2016

Jul 08, 2025

BUY
N/A
11,036 Added 111.73%
20,913 $3.18 Billion
Q1 2016

Jul 08, 2025

BUY
N/A
9,877 New
9,877 $1.48 Billion
Q3 2011

Jul 07, 2025

SELL
N/A
-1,600 Closed
0 $0
Q2 2011

Jul 07, 2025

SELL
N/A
-600 Reduced 27.27%
1,600 $93.4 Million
Q1 2011

Jul 07, 2025

BUY
N/A
2,200 New
2,200 $118 Million
Q4 2010

Jul 03, 2025

SELL
N/A
-1,000 Reduced 38.46%
1,600 $87.8 Million
Q3 2010

Jul 03, 2025

BUY
N/A
2,600 New
2,600 $143 Million
Q4 2009

Jul 03, 2025

SELL
N/A
-2,900 Closed
0 $0
Q3 2009

Jul 03, 2025

BUY
N/A
2,900
2,900 $175 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Northwest & Ethical Investments L.P. Portfolio

Follow Northwest & Ethical Investments L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest & Ethical Investments L.P., based on Form 13F filings with the SEC.

News

Stay updated on Northwest & Ethical Investments L.P. with notifications on news.